Table 3 Symptoms and interventions after infection with COVID-19
Variables | All (n = 39) | Decreased oxygen saturation (n = 12) | Non decreased oxygen saturation (n = 27) | P value |
|---|---|---|---|---|
Dyspnea | < 0.001 | |||
Never | 26 (66.7%) | 3 (25.0%) | 23 (85.2%) | |
New-onset | 7 (17.9%) | 5 (41.7%) | 2 (7.4%) | |
Worsen | 6 (15.4%) | 4 (33.3%) | 2 (7.4%) | |
Interventions | ||||
Outpatient or emergency | 13 (33.3%) | 6 (50.0%) | 7 (25.9%) | 0.163 |
NSAIDs or analgesics | 36 (92.3%) | 11 (91.7%) | 25 (92.6%) | 1.000 |
Systemic corticosteroids | 3 (7.7%) | 3 (25.0%) | 0 (0.0%) | 0.024 |
Antibiotics | 9 (23.1%) | 6 (50.0%) | 3 (11.1%) | 0.014 |
Hospitalized | 4 (10.3%) | 4 (33.3%) | 0 (0.0%) | 0.006 |
GM-CSF inhalation | 0.222 | |||
Never | 26 (66.7%) | 6 (50.0%) | 20 (74.1%) | |
Continuously used | 8 (20.5%) | 3 (25.0%) | 5 (18.5%) | |
Discontinue | 5 (12.8%) | 3 (25.0%) | 2 (7.4%) | |